REQUEST A DEMO
Total
USD $0.00
Search more companies

BL Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BL Corporation Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bioleaders Corporation is engaged in manufacturing and distribution of innovative therapies and medicines. The company develops orally-delivered prescription prophylactic and therapeutic applications and medicines for Human papillomavirus (HPV-) related diseases, Anti-virals for infectious diseases, Immunostimulatory therapeutics for cancer, dermatology, and vaccine adjuvants, and Immunotherapy vaccines for oncology, cardiovascular, CNS, and muscle-wasting diseases. Bioleaders Corporation is based in Daejeon, South Korea. The company was incorporated in 2000.

Headquarters
13 Techno 8-Ro, Yuseong-Gu
Daejeon; Daejeon; Postal Code: 34028

Contact Details: Purchase the BL Corporation report to view the information.

Website: http://www.bioleaders.co.kr

Basic Information
Total Employees:
Purchase the BL Corporation report to view the information.
Outstanding Shares:
Purchase the BL Corporation report to view the information.
Registered Capital:
Purchase the BL Corporation report to view the information.
Financial Auditors:
Purchase the BL Corporation report to view the information.
Incorporation Date:
December 30, 1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
9.3%
Purchase this report to view the information.
0.3%
Purchase this report to view the information.
0.1%
Subsidiaries
그린코어밸류업1호 사모투자 합자회사
98.2%
(주)넥스트비티
39.78%
Company Performance
Financial values in the chart are available after BL Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-84.16%
Total operating revenue
-87.05%
Operating profit (EBIT)
-88.1%
Net Profit (Loss) for the Period
34.5%
Total assets
-52.44%
Total equity
-28.66%
Operating Profit Margin (ROS)
-28.99%
Net Profit Margin
-21.3%
Return on Equity (ROE)
0.5%
Debt to Equity Ratio
-44.02%
Quick Ratio
2.22%
Cash Ratio
0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?